During the past decade, North Hills Medical Research, Inc conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Hills Medical Research, Inc" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "George Medicines PTY Limited" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Brigham and Women's Hospital" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Hills Medical Research, Inc" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "North Hills Medical Research, Inc" are "Type 2 Diabetes" (4 trials), "Cardiovascular Disease" (3 trials), "Hypertension" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "North Hills Medical Research, Inc" in a lesser frequency.

Most popular intervention types in "North Hills Medical Research, Inc" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Dapagliflozin" (3 trials), "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg" (2 trials), "Tirzepatide" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Hills Medical Research, Inc" are 13 trials for "All" genders.

Currently, there are NaN active trials in "North Hills Medical Research, Inc". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in North Hills Medical Research, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Hills Medical Research, Inc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".